Oncoimmunins

Details Oncoimmunins Oncoimmunins

1991-09-23

1994-11-15

Schain, Howard E.

Drug, bio-affecting and body treating compositions

Lymphokine

424 852, 530350, 530351, 514 2, A61K 3702

Patent

active

053646193

ABSTRACT:
The present invention relates, in general, to oncoimmunins. In particular, the present invention relates to oncoimmunin-lymphoid factor and oncoimmunin-myeloid factor, pharmaceutical compositions of said factors, and methods of use of said factors.

REFERENCES:
patent: 4863727 (1989-09-01), Zimmerman et al.
R. Andreesen & B. Hennemann "Adoptive Immunotherapy with Autol. Macrophage . . . Perspectives", Macrophage, Ann Conf upper Rhine Univ(II) Pathobiology 1991; 59; 259-63.
Bartholeyns, J. M. Lopez and R. Andreeson "Adoptive Immunotherapy Clinical Results,"Anticancer Res. 11: 1201-1204 (1991).
Andreesen et al. "A New Approach to . . . Blood Monocytes" Cancer Prevention and Detection, vol. 15, Issue #5, pp. 413-421.
Packard, B. S. "Mitogenic stimulation of human tumor-infiltrating Lymphocytes . . . cell lines", PNAS, 87: pp. 4058-4062, 1990.
Vose, B. M. et al. Human Tumour Antigens Defined by Cytotoxicity and Proliferative Responses of Cultured Lymphoid Cells, Nature (London), vol. 296, pp. 359-361 (1982).
Vose, B. M. et al., Specific Cytotoxicity Against Autologous Tumours and Proliferative Responses of Human Lymphocytes Grown in Interleukin 2, Int. J. Cancer, vol. 29, pp. 33-39 (1982).
Vanky, F. et al., Lysis of Tumor Biopsy Cells by Autologous T Lymphocytes Activated in Mixed Cultures and Propogated with T Cell Growth Factor, J. Exp. Med. vol. 155, pp. 83-95 (1982).
Mitsuya et al., Generation of an HLA-Restricted Cytotoxic T Cell Line Reactive Against Cultured Tumor Cells from A Patient Infected with Human T Cell Leukemia/Lymphoma Virus, J. Exp. Med., vol. 158, pp. 994-999 (1983).
De Vries, J. E. et al., Cloned Human Cytotoxic T Lymphocyte (CTL) Lines Reactive With Autologous Melanoma Cells, J. Immunol., vol. 132, pp. 510-519 (1984).
Slovin, S. F. et al., Cellular Immune Response to Human Sarcomas: Cytotoxic T Cell Clones Reactive With Autologous Sarcomas, vol. 137, pp. 3042-3048 (1986).
Itoh, K. et al., Interleukin 2 Activation of Cytotoxic T-Lymphocytes Infiltrating into Human Metastatic Melanomas, Cancer Res., vol. 46, pp. 3011-3017 (1986).
Rosenberg et al., A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating Lymphocytes, Science, vol. 233, pp. 1318-1321 (1986).
Rabinowich, H. et al., Functional Analysis of Mononuclear Cells Infiltrating into Tumors: Lysis of Autologous Human Tumor Cells by Cultured Infiltrating Lymphocytes, Cancer Res., vol. 47, pp. 173-177 (1987).
Miescher, T. et al., Clonal and Frequency Analyses of Tumor-Infiltrating T Lymphocytes From Human Solid Tumors, J. Immunol., vol. 138, pp. 4004-4011 (1987).
Kadin, R. L. et al., Tumor-derived Interleukin-2-dependent Lymphocytes in Adoptive Immunotherapy of Lung Cancer, vol. 24, pp. 76-86 (1987).
Rosenberg, S. A. et al., Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients With Metastatic Melanoma, N. Engl. J. Med., vol. 319, pp. 1676-1680 (1988).
Smith, K. A. Interleukin-2: Inception, Impact, and Implications, Science, vol. 240, pp. 1169-1176 (1988).
Topalian, S. L. et al., Expansion of Human Tumor Infiltrating Lymphocytes for Use in Immunotherapy Trials, J. Immunol., vol. 102, pp. 127-141 (1987).
Packard, B. S., Identification of a Synthetic Nonapeptide Sequence that Inhibits Motility in Culture of a Melanoma Subclone that Possesses a High Metastatic Potential, Proc. Natl. Acad. Sci., vol. 84, pp. 9015-9019 (1987).
Kirnbauer, R. et al., IFN-.beta.2 Cell Differentiation Factor 2, or Hybridoma Growth Factor (IL-6) is Expressed And Released by Human Epidermal Cells and Epidermoid Carcinoma Cell Lines, J. Immuno., vol. 142, pp. 1922-1928 (1987).
Packard, B. S., The Use of Tumor-Infiltrating Lymphocytes in Cancer Therapy, In: Progress Regional Cancer Therapy, eds Jakcez, R. et al., (Springer Heidelberg), pp. 293-303 (1990).
Smith, K. A., The Interleukin 2 Reporter, Adv. Immunol., vol. 42, pp. 165-179 (1988).
Quinan, C. V., Points to Consider in the Collection, Processing and Testing of Ex Vivo Activated Mononuclear Leukocytes for Administration to Humans, Publication of Center for Biologics Evaluations and Research, Food and Drug Administration (1989).
Packard, Beverly S., Mitogenic stimulation of human tumor-infiltrating lymphocytes by secreted factor(s) from human tumor cell lines, Proc. Natl. Acad. Sci. USA (1990), vol. 87, pp. 4058-4062.
Packard, Beverly S. et al., Identification of a New Growth Factor for Lymphocytes: Mitogenic Stimulation of Lymphocytes by Tumor Cell Lines, Federation of American Society of Experimental Biology (Apr. 1991) Atlanta, Ga.
Packard, Beverly, Identification of a new class of growth factors: tumor-derived lymphocytes mitogens, Biophysical Society of America (Feb. 1991) San Francisco, California.
Packard, Beverly S., Mitogenic Stimulation of Human T Cells by Solid Tumor Lines Mediated by Secreted Proteins, Biophysical Society of America (Feb. 1990), Baltimore, Maryland.
Packard, B., Mitogenic stimulation of human tumor infiltrating lymphocytes by human cell lines, American Association of Cancer Research (May 1990), Washington, D.C.
Packard, Beverly S. et al., Mitogenic stimulation of human tumor infiltrating lymphocytes by human cell lines (Mar. 1990), Florence, Italy.
Packard, B. S., A New Mitogen Derived From a Tumor Cell Line for Tumor Infiltrating Lymphocytes (TILS), American Society of Cell Biology (Nov. 1989), Houston, Texas.
Packard, Beverly, A New Mitogen for Tumor Infiltrating Lymphocytes (TILS) Derived from a Tumor Cell Line (Nov. 1989), Hilton Head, South Carolina.
Packard, Beverly S., Mitogenic Stimulation of Human T Cells by Solid Tumor Lines Mediated by Secreted Proteins (Jul. 1989), Berlin, West Germany.
Treves, Abraham, et al., Immunotherapy of Lethal Metastases by Lymphocytes Sensitized Against Tumor Cells In Vitro., J. Natl. Cancer Inst., vol. 54, No. 3, pp. 777-780 (1975).
Lee, S. K. et al., Autologous Leukemia-Specific T-Cell-Mediated Lymphocytotoxicity in Patients with Acute Myelogenous Leukemia, J. Exp. Med., vol. 147, pp. 912-922 (1978).
Zarling, J. M. et al., Continuous Culture of T Cells Cytotoxic for Autologous Human Leukaemia Cells, Nature (London), vol. 280, pp. 685-587 (1979).

Affiliated with

Also associated with

Rating

Oncoimmunins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oncoimmunins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oncoimmunins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1095641